Ahmed Hamdy MD - 23 Jun 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Executive Officer, Director
Signature
By: /s/ Alexander A. Seelenberger, Attorney-in-Fact
Issuer symbol
VINC
Transactions as of
23 Jun 2022
Net transactions value
+$34,137
Form type
4
Filing time
27 Jun 2022, 19:20:13 UTC
Previous filing
16 Feb 2022
Next filing
29 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VINC Common Stock Purchase $34,137 +24,200 +169% $1.41 38,480 23 Jun 2022 The Hamdy Family Trust dated 10/7/2015 F1
holding VINC Common Stock 1,618,199 23 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents actual price.